FDA Drug Recalls

Recalls / Class II

Class IID-1133-2023

Product

oxyTOCIN 30 units added to 0.9% sodium chloride 500 mL, IV Bag, Rx only, CAPS, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-6044-1

Affected lot / code info
Lot# 36-260031, 36-260027, Exp 10/3/2023; 36-262533,36-262532, 36-262531, 36-262530, 36-262529, 36-262528, 36-262527, Exp 10/9/2023. ;

Why it was recalled

Lack of Assurance of Sterility:Lack of validation data for sanitization cycles

Recalling firm

Firm
Central Admixture Pharmacy Services, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
2200 S 43rd Ave, N/A, Phoenix, Arizona 85043-3909

Distribution

Quantity
2643 bags
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2023-08-17
FDA classified
2023-08-28
Posted by FDA
2023-09-06
Terminated
2025-03-27
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1133-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls